Related Experiment Videos
Dose-response analysis in risk assessment: evaluation of behavioral specificity
1Laboratory of Medicinal Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA. G7W@cu.nih.gov
Environmental Health Perspectives
|April 1, 1996
Summary
This study advances probabilistic risk assessment for neurotoxic effects. Researchers found that GBR 12909 demonstrated specific therapeutic benefits against cocaine-seeking behavior with minimal unwanted side effects in monkeys.
Area of Science:
- Neuroscience
- Toxicology
- Pharmacology
Background:
- Quantitative risk assessment methods are crucial for evaluating neurotoxic effects.
- Existing methods include benchmark and probabilistic approaches, with a focus on dose-response data.
- Probabilistic approaches are being extended for neurotoxic endpoints, utilizing dose variability.
Purpose of the Study:
- To extend probabilistic approaches for neurotoxic endpoints.
- To assess the relative risks of therapeutic efficacy versus behavioral toxicity for a given agent.
- To investigate the therapeutic potential and toxicity of GBR 12909 using behavioral endpoints.
Main Methods:
- Utilized quantitative risk assessment, specifically extending probabilistic approaches.
- Focused on behavioral data to assess both therapeutic efficacy and toxicity.
- Administered GBR 12909 to monkeys, measuring effects on cocaine-maintained and food-maintained responding.
Main Results:
- GBR 12909 decreased both cocaine-maintained (drug-seeking) and food-maintained (general behavior) responding in monkeys.
- Complete suppression of drug-seeking behavior occurred at doses with minimal impact on food-maintained responding.
- The differential effects suggest a therapeutic window where specific benefits can be achieved without significant adverse effects.
Conclusions:
- Probabilistic risk assessment can be effectively applied to neurotoxic endpoints using behavioral data.
- Multiple behavioral endpoints are valuable for identifying specific chemical effects in risk assessment.
- GBR 12909 shows potential for specific therapeutic effects in managing drug-seeking behavior with a manageable toxicity profile.